Edwards Lifesciences Gets CE Mark

Edwards Lifesciences has received a CE mark for its Pascal Precision transcatheter valve repair system for treatment of mitral and tricuspid valve regurgitation.

The system features implants that can elongate and navigate complex anatomy and a rail-based system with multiple stabilizers to advance, retract and torque catheters.

The Pascal system is one of multiple transcatheter repair or replacement systems the company is developing to address mitral and tricuspid valve diseases.

Edwards Lifesciences focuses on developing medical products for treatment of structural heart disease, critical care and surgical monitoring.